NCT04508946View on ClinicalTrials.gov

Triple Therapy in Septic Shock Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

November 9, 2020

Study Completion Date

November 9, 2020

Conditions
Septic ShockSepsisOrgan Dysfunction Syndrome Sepsis
Interventions
DRUG

vitamin c - thiamine- hydrocortisone

Triple therapy regimen (vitamin c - thiamine- hydrocortisone)

Trial Locations (1)

4260010

Air Force Specialized Hospital, Cairo

All Listed Sponsors
lead

Air Force Specialized Hospital, Cairo, Egypt

OTHER

NCT04508946 - Triple Therapy in Septic Shock Patients | Biotech Hunter | Biotech Hunter